The 20th Conference on Retroviruses and Opportunistic Infections (CROI) occurs March 3-6, 2013 at the Georgia World Congress Center, Atlanta, Gerogia.
CROI is a scientifically focused meeting of the world’s leading researchers working to understand, prevent, and treat HIV/AIDS and its complications. The goal of CROI is to provide a forum for translating laboratory and clinical research into progress against the AIDS epidemic. Over 4,000 leading researchers and clinicians from around the world convene in a different location each year for the Conference.
The following HNRC presentations (in alphabetical order by title) were accepted at CROI.
- Letendre S, Vaida F, Wong S, Croteau D, FitzSimons C, Grant I, Ellis R. Long-term efavirenz use is associated with worse neurocognitive functioning.
- Letendre S, McClernon D, Deutsch R, Cherner M, Cookson, Crescini M, Grant I, Ellis R. Low-level HIV RNA declines over time in csf but not in plasma.
- Ellis R, Vaida F, Letendre S, Haubrich R, Heaton RK, McCutchan JA, Cherner M, Umlauf A, Sacktor N, Clifford DB. Randomized trial of CNS-penetrating antiretroviral therapy for HIV-associated cognitive impairment.
- Tilghman MW, Deshpande S, Battacharya J, Ghate M, Marcotte T, Smith D, Mehendale S. Viral signatures in HIV-1 subtype C tat are associated with neurocognitive impairment in an Indian cohort.
Click Here to view poster if available (if there is link to the left of the publication title).